查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1515507

非病毒轉染試劑和系統市場，按類型、應用、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Non-Viral Transfection Reagents and Systems Market, By Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 299 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年非病毒轉染試劑和系統市場規模為 7.8623 億美元，2024 年至 2032 年複合年成長率為 8.2%。

非病毒轉染試劑與系統市場-市場動態

臨床環境對非病毒轉染試劑的需求正在推動其市場成長。

非病毒轉染是現有方法的一種引人注目的替代方法，具有獨特的優勢。這些優勢包括加快時間安排、提高生物效率、降低細胞毒性以及提供更多種核酸的能力。非病毒轉染試劑在臨床應用中的關鍵作用是其成長的關鍵驅動力。這些試劑有助於遞送治療性核酸，例如 siRNA、miRNA 和編碼治療性蛋白的 DNA 質粒或 CRISPR/Cas9 基因組編輯工具。這種能力為開發針對多種疾病的創新基因療法鋪平了道路，包括遺傳性疾病、癌症和傳染病。

目前的情況反映出許多公司積極開發先進的非病毒轉染試劑和系統的活動激增。例如，最近，細胞治療專家 BioCentriq 和 MIT 新創公司 Kytopen 聯手開發創新的細胞治療製造技術。

非病毒轉染試劑與系統市場-關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 8.2% 左右的複合年成長率成長

根據類型細分，預計非疾病轉染試劑將在 2023 年顯示最大的市場佔有率

從應用細分來看，2023年研究類應用為主導類型

根據最終用戶細分，製藥公司是 2023 年的主導類型

按地區分類，亞太地區是 2023 年的主要收入來源

非病毒轉染試劑與系統市場區隔分析：

全球非病毒轉染試劑和系統市場根據類型、應用、最終用戶和地區進行細分。

市場依類型分為三類：非病毒轉染試劑、基於電穿孔的轉染系統、其他非病毒轉染系統。電穿孔涉及在核酸存在的情況下向細胞施加電脈衝，在細胞膜上形成臨時孔，遺傳物質可以通過該孔進入。電穿孔以其高轉染效率而聞名，對於難以轉染的細胞和原代細胞特別有效。它可用於瞬時和穩定轉染，但需要專門的設備並針對不同細胞類型進行最佳化。

市場根據應用分為兩類：臨床和研究。基於非病毒轉染試劑的研究涵蓋了廣泛的生物和生物醫學領域。例如在基因功能研究中，研究人員使用非病毒轉染試劑將特定基因或調控元件引入細胞中。這使他們能夠研究基因表現模式、調控機制以及基因在各種細胞過程中的作用。

非病毒轉染試劑與系統市場-地理洞察

由於研發方面的大量投資，亞太地區的生物技術和製藥產業正在迅速擴張。這種成長在中國、日本和韓國等國家尤其明顯。因此，對非病毒轉染試劑的需求不斷增加。這些試劑對於將遺傳物質精確遞送至目標細胞以及支持基因治療和基因編輯技術的發展至關重要。此外，遺傳性疾病盛行率的增加導致該地區生物醫學研究和治療進展對這些試劑的需求增加。例如，巴基斯坦人口組成的多樣化，以顯著的血緣關係為特徵，導致遺傳性疾病病例的盛行率較高。

非病毒轉染試劑與系統市場競爭格局：

非病毒轉染試劑和系統市場的一些主要參與者包括 Thermo Fisher Scientific、Bio-Rad Laboratories、Inovio Pharmaceuticals 和 MaxCyte。每個人都帶來獨特的技術和專業知識來推進涉及基因操作和細胞工程的研究和治療應用。例如，MaxCyte 正在為原代細胞、幹細胞和細胞系的瞬時和穩定轉染提供可擴展的解決方案。 MaxCyte 的系統因其高轉染效率、可擴展性以及在研究和臨床環境中的適用性而受到重視。

Bio-Rad 實驗室專注於基於電穿孔的轉染系統，該系統透過施加電脈衝將核酸高效地輸送到細胞中。 Bio-Rad 的系統廣泛用於研究和生物製藥應用中難以轉染的細胞和原代細胞。

最近的發展：

2023 年 9 月，一家源自諾丁漢大學的新企業，與其合作夥伴諾丁漢大學一起，致力於開發用於骨移植增強的乾粉基因治療配方，獲得了英國創新機構 Innovate UK 的 995,000 英鎊資助機構。

2023 年 8 月，Altogen Biosystems 推出了一種專注試劑，旨在將生物分子轉運至肺部，用於治療肺部疾病患者。該藥物能夠安全有效地將小分子、DNA、RNA 和蛋白質運送到肺部。

目錄

第 1 章：非病毒轉染試劑與系統市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的非病毒轉染試劑和系統市場片段
    • 非病毒轉染試劑和系統市場片段（依應用）
    • 最終用戶的非病毒轉染試劑和系統市場片段
    • 按國家/地區分類的非病毒轉染試劑和系統市場片段
    • 按地區分類的非病毒轉染試劑和系統市場片段
  • 競爭洞察

第 3 章：非病毒轉染試劑與系統主要市場趨勢

  • 非病毒轉染試劑與系統市場促進因素
    • 市場促進因素的影響分析
  • 非病毒轉染試劑與系統市場限制
    • 市場限制影響分析
  • 非病毒轉染試劑和系統的市場機會
  • 非病毒轉染試劑與系統市場未來趨勢

第 4 章：非病毒轉染試劑與系統產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：非病毒轉染試劑與系統市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：非病毒轉染試劑與系統市場格局

  • 2023 年非病毒轉染試劑與系統市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：非病毒轉染試劑和系統市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 非病毒轉染試劑
    • 基於電穿孔的轉染系統
    • 其他非病毒轉染系統

第 8 章：非病毒轉染試劑和系統市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 臨床
    • 研究

第 9 章：非病毒轉染試劑和系統市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 學術與研究
    • 製藥公司
    • 其他

第 10 章：非病毒轉染試劑和系統市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美非病毒轉染試劑和系統主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲非病毒轉染試劑和系統主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區非病毒轉染試劑和系統主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲非病毒轉染試劑和系統主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲非病毒轉染試劑和系統主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 非病毒轉染試劑和系統產業

  • 競爭儀表板
  • 公司簡介
    • Thermo Fisher Scientific (TFS)
    • Lonza Group
    • Imunon (Formerly known as Celsion)
    • Promega Corporation
    • Altogen Biosystems
    • Mirus Bio LLC
    • Genprex
    • Polyplus-Transfection SA
    • Bio-Rad Laboratories
    • MaxCyte
    • MilliporeSigma
    • Qiagen
    • Takara Bio

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV3258

REPORT HIGHLIGHT

Non-Viral Transfection Reagents and Systems Market size was valued at USD 786.23 Million in 2023, expanding at a CAGR of 8.2% from 2024 to 2032.

Non-viral transfection reagents are substances used in molecular biology and biotechnology to deliver genetic material (such as DNA or RNA) into cells without the use of viral vectors. They facilitate the introduction of nucleic acids into cells for various purposes, including gene expression studies, protein production, gene therapy, and genome editing.

Non-Viral Transfection Reagents and Systems Market- Market Dynamics

The need for Non-Viral Transfection Reagents in clinical settings is fueling their market growth.

Non-viral transfection is a compelling alternative to established methods, offering distinct advantages. These advantages include expedited timelines, enhanced biological efficiency, reduced cytotoxicity, and the ability to deliver a wider variety of nucleic acids. The pivotal role of non-viral transfection reagents in clinical applications is a key driver of their growth. These reagents facilitate the delivery of therapeutic nucleic acids, such as siRNA, miRNA, and DNA plasmids encoding therapeutic proteins or CRISPR/Cas9 genome editing tools. This capability paves the way for the development of innovative gene therapies for a broad spectrum of conditions, including genetic disorders, cancers, and infectious diseases.

The current landscape reflects a surge in activity by numerous companies actively developing advanced non-viral transfection reagents and systems. For example, recently, BioCentriq, a cell therapy expert, and Kytopen, an MIT startup, teamed up to develop innovative cell therapy manufacturing technology.

Non-Viral Transfection Reagents and Systems Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.2% over the forecast period (2024-2032)

Based on Type segmentation, non-viral transfection reagents were predicted to show maximum market share in the year 2023

Based on Application segmentation, Research Applications was the leading type in 2023

Based on End User segmentation, Pharmaceutical Companies were the leading type in 2023

Based on region, Asia-Pacific was the leading revenue generator in 2023

Non-Viral Transfection Reagents and Systems Market- Segmentation Analysis:

The Global Non-Viral Transfection Reagents and Systems Market is segmented based on Type, Application, End User, and Region.

The market is divided into three categories based on Type: Non-Viral Transfection Reagents, Electroporation-based Transfection Systems and Other Non-Viral Transfection Systems. Electroporation involves applying electrical pulses to cells in the presence of nucleic acids, creating temporary pores in the cell membrane through which genetic material can enter. Electroporation is known for its high transfection efficiency and is particularly effective for difficult-to-transfect cells and primary cells. It can be used for transient and stable transfection but requires specialized equipment and optimization for different cell types.

The market is divided into two categories based on Application: Clinical and Research. Research based on non-viral transfection reagents spans a wide spectrum of biological and biomedical fields. Such as in gene function studies, researchers employ non-viral transfection reagents to introduce specific genes or regulatory elements into cells. This allows them to study gene expression patterns, regulatory mechanisms, and the roles of genes in various cellular processes.

Non-Viral Transfection Reagents and Systems Market- Geographical Insights

The biotechnology and pharmaceutical industries in the Asia-Pacific region are expanding swiftly due to substantial investments in research and development. This growth is particularly pronounced in countries such as China, Japan, and South Korea. As a result, there is an increasing need for non-viral transfection reagents. These reagents are crucial for delivering genetic material precisely to target cells and supporting the development of gene therapy and gene editing technologies. Moreover, the rising prevalence of genetic disorders is contributing to the heightened demand for these reagents in the region's biomedical research and therapeutic advancements. For instance, the diverse makeup of Pakistan's population, characterized by significant levels of consanguinity, contributes to the higher prevalence of genetic disorders cases.

Non-Viral Transfection Reagents and Systems Market- Competitive Landscape:

Some of the key players in the Non-Viral Transfection Reagent and Systems Market are Thermo Fisher Scientific, Bio-Rad Laboratories, Inovio Pharmaceuticals, and MaxCyte. Each brings unique technologies and expertise to advance research and therapeutic applications involving genetic manipulation and cell engineering. For example, MaxCyte, is offering scalable solutions for transient and stable transfection of primary cells, stem cells, and cell lines. MaxCyte's systems are valued for their high transfection efficiency, scalability, and applicability in research and clinical settings.

Bio-Rad Laboratories specialises in electroporation-based transfection systems, which offer high efficiency for delivering nucleic acids into cells by applying electrical pulses. Bio-Rad's systems are widely used for difficult-to-transfect cells and primary cells in research and biopharmaceutical applications.

Recent Developments:

In Sept 2023, A new enterprise stemming from the University of Nottingham, dedicated to advancing a dry powder gene therapy formulation for bone graft augmentation, along with its partner, the University of Nottingham, has been granted £995,000 by Innovate UK, the UK's innovation agency.

In August 2023, Altogen Biosystems introduced a focused reagent designed to transport biomolecules to the lungs for treating patients with pulmonary diseases. The drug has safely and effectively transported small molecules, DNA, RNA, and proteins to the lungs.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NON-VIRAL TRANSFECTION REAGENTS AND SYSTEMS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Thermo Fisher Scientific (TFS)

Lonza Group

Imunon (Formerly known as Celsion)

Promega Corporation

Altogen Biosystems

Mirus Bio LLC

Genprex

Polyplus-Transfection SA

Bio-Rad Laboratories

MaxCyte

MilliporeSigma

Qiagen

Takara Bio

GLOBAL NON-VIRAL TRANSFECTION REAGENTS AND SYSTEMS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Non-Viral Transfection Reagents
  • Electroporation-based Transfection Systems
  • Other Non-Viral Transfection Systems

GLOBAL NON-VIRAL TRANSFECTION REAGENTS AND SYSTEMS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Clinical
  • Research

GLOBAL NON-VIRAL TRANSFECTION REAGENTS AND SYSTEMS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Academic and Research
  • Pharmaceutical Companies
  • Others

GLOBAL NON-VIRAL TRANSFECTION REAGENTS AND SYSTEMS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Non-Viral Transfection Reagents and Systems Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Non-Viral Transfection Reagents and Systems Market Snippet by Type
    • 2.1.2. Non-Viral Transfection Reagents and Systems Market Snippet by Application
    • 2.1.3. Non-Viral Transfection Reagents and Systems Market Snippet by End User
    • 2.1.4. Non-Viral Transfection Reagents and Systems Market Snippet by Country
    • 2.1.5. Non-Viral Transfection Reagents and Systems Market Snippet by Region
  • 2.2. Competitive Insights

3. Non-Viral Transfection Reagents and Systems Key Market Trends

  • 3.1. Non-Viral Transfection Reagents and Systems Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Non-Viral Transfection Reagents and Systems Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Non-Viral Transfection Reagents and Systems Market Opportunities
  • 3.4. Non-Viral Transfection Reagents and Systems Market Future Trends

4. Non-Viral Transfection Reagents and Systems Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Non-Viral Transfection Reagents and Systems Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Non-Viral Transfection Reagents and Systems Market Landscape

  • 6.1. Non-Viral Transfection Reagents and Systems Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Non-Viral Transfection Reagents and Systems Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Non-Viral Transfection Reagents
    • 7.1.3. Electroporation-based Transfection Systems
    • 7.1.4. Other Non-Viral Transfection Systems

8. Non-Viral Transfection Reagents and Systems Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Clinical
    • 8.1.3. Research

9. Non-Viral Transfection Reagents and Systems Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Academic and Research
    • 9.1.3. Pharmaceutical Companies
    • 9.1.4. Others

10. Non-Viral Transfection Reagents and Systems Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Non-Viral Transfection Reagents and Systems Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Non-Viral Transfection Reagents and Systems Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Non-Viral Transfection Reagents and Systems Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Non-Viral Transfection Reagents and Systems Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Non-Viral Transfection Reagents and Systems Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Non-Viral Transfection Reagents and Systems Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific (TFS)
    • 11.2.2. Lonza Group
    • 11.2.3. Imunon (Formerly known as Celsion)
    • 11.2.4. Promega Corporation
    • 11.2.5. Altogen Biosystems
    • 11.2.6. Mirus Bio LLC
    • 11.2.7. Genprex
    • 11.2.8. Polyplus-Transfection SA
    • 11.2.9. Bio-Rad Laboratories
    • 11.2.10. MaxCyte
    • 11.2.11. MilliporeSigma
    • 11.2.12. Qiagen
    • 11.2.13. Takara Bio

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Non-Viral Transfection Reagents and Systems Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Non-Viral Transfection Reagents and Systems Market, by Type 2019-2032 (USD Million)
  • TABLE Non-Viral Transfection Reagents and Systems Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Non-Viral Transfection Reagents and Systems Market, by Application 2019-2032 (USD Million)
  • TABLE Non-Viral Transfection Reagents and Systems Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Non-Viral Transfection Reagents and Systems Market, by End User 2019-2032 (USD Million)
  • TABLE Non-Viral Transfection Reagents and Systems Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Non-Viral Transfection Reagents and Systems Market, by Region 2019-2032 (USD Million)
  • TABLE North America Non-Viral Transfection Reagents and Systems Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Non-Viral Transfection Reagents and Systems Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Non-Viral Transfection Reagents and Systems Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Non-Viral Transfection Reagents and Systems Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Non-Viral Transfection Reagents and Systems Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Non-Viral Transfection Reagents and Systems Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Non-Viral Transfection Reagents and Systems Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Non-Viral Transfection Reagents and Systems Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Non-Viral Transfection Reagents and Systems Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Non-Viral Transfection Reagents and Systems Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Non-Viral Transfection Reagents and Systems Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Non-Viral Transfection Reagents and Systems Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Non-Viral Transfection Reagents and Systems Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Non-Viral Transfection Reagents and Systems Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Non-Viral Transfection Reagents and Systems Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Non-Viral Transfection Reagents and Systems Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Non-Viral Transfection Reagents and Systems Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Non-Viral Transfection Reagents and Systems Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Non-Viral Transfection Reagents and Systems Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Non-Viral Transfection Reagents and Systems Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Non-Viral Transfection Reagents and Systems Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Type segment market share analysis, 2023 & 2032
  • FIGURE Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Non-Viral Transfection Reagents and Systems Market share and leading players, 2023
  • FIGURE Europe Non-Viral Transfection Reagents and Systems Market share and leading players, 2023
  • FIGURE Asia Pacific Non-Viral Transfection Reagents and Systems Market share and leading players, 2023
  • FIGURE Latin America Non-Viral Transfection Reagents and Systems Market share and leading players, 2023
  • FIGURE Middle East and Africa Non-Viral Transfection Reagents and Systems Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Non-Viral Transfection Reagents and Systems Market share analysis by country, 2023
  • FIGURE Germany Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Non-Viral Transfection Reagents and Systems Market share analysis by country, 2023
  • FIGURE India Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Non-Viral Transfection Reagents and Systems Market share analysis by country, 2023
  • FIGURE Brazil Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Non-Viral Transfection Reagents and Systems Market share analysis by country, 2023
  • FIGURE Saudi Arabia Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Non-Viral Transfection Reagents and Systems Market size, forecast and trend analysis, 2019 to 2032 (USD Million)